KCCQ total symptom score, clinical outcome measures, and adverse events associated with omecamtiv mecarbil for heart failure with reduced ejection fraction: a …
R Ibrahim, A Olagunju, K Terrani, C Takamatsu… - Clinical Research in …, 2023 - Springer
Background Omecamtiv mecarbil (OM) is a direct myosin activator that augments left
ventricular systolic function. This review compares OM to placebo by evaluating its effect on …
ventricular systolic function. This review compares OM to placebo by evaluating its effect on …
Pharmacological Treatment of Heart Failure: Recent Advances
JCH Chan, A Siddiqui - Current Cardiology Reviews, 2024 - ingentaconnect.com
Background: Heart failure is a clinical condition with high mortality and morbidity that occurs
when the heart is unable to pump enough blood to meet the metabolic demands of the body …
when the heart is unable to pump enough blood to meet the metabolic demands of the body …
Gambaran Peran Keluarga Dalam Perawatan Pasien Gagal Jantung: Perspektif Pasien
MT Hardiyana, B Kristinawati - Health Information …, 2023 - myjurnal.poltekkes-kdi.ac.id
Heart failure is a significant health problem both in the world and in Indonesia, and its
morbidity and mortality rates are high. This condition is associated with low self-care …
morbidity and mortality rates are high. This condition is associated with low self-care …
Reverse Remodeling of Methamphetamine-Associated Cardiomyopathy: An Update on Mechanisms for Recovery
JR Richards, AR Danielson, RP Stuart… - Medical Research …, 2024 - esmed.org
Methamphetamine (MA) use continues to rise worldwide. The adverse effects of MA on the
cardiovascular system include cardiomyopathy, dysrhythmias, coronary arterial vasospasm …
cardiovascular system include cardiomyopathy, dysrhythmias, coronary arterial vasospasm …